UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052516
Receipt number R000059928
Scientific Title Measuring the degree of venous dilatation based on changes in avascular blood pressure and avascularization time
Date of disclosure of the study information 2023/10/17
Last modified on 2024/04/18 11:50:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measuring the degree of venous dilatation based on changes in avascular blood pressure and avascularization time

Acronym

Degree of venous dilatation due to changes in avascular conditions

Scientific Title

Measuring the degree of venous dilatation based on changes in avascular blood pressure and avascularization time

Scientific Title:Acronym

Degree of venous dilatation due to changes in avascular conditions

Region

Japan


Condition

Condition

Patients undergoing oral and oral surgery surgery under general anesthesia

Classification by specialty

Anesthesiology Oral surgery Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although the thickness of blood vessels varies from person to person, the apoptotic blood pressure and apoptotic time at which dilation reaches its maximum have not yet been investigated. This is because there is a possibility that the subject's mental state may be affected. This research will be conducted under general anesthesia, making it highly scientifically rational.

Basic objectives2

Others

Basic objectives -Others

Appropriate avascular blood pressure and avascularization time

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Vein cross-sectional area

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Blood aversion with mean blood pressure + pulse pressure

Interventions/Control_2

Blood aversion at average blood pressure

Interventions/Control_3

Blood abolition at the pressure of mean blood pressure - pulse pressure/2

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing minor dental surgery (surgeries within 4 hours, such as wisdom tooth extraction, jawbone cyst removal, and benign tumor removal) at our dental/oral and oral surgery department. In addition, patients who meet all of the following conditions will be targeted.
1) Target patient age: 20-39 years old
2) Gender: Regardless of gender
3) Past medical history/severity of comorbidities: Those who have been evaluated as Class I or II in the Physical status (ASA-PS classification) defined by the American Society of Anesthesiologists (ASA).
4) Inpatient/Outpatient: All inpatient cases. To check if there are any effects from postoperative studies.
5) Surgery/anesthesia: Surgery completed as planned without requiring blood transfusion due to heavy bleeding.
6)Patients who have received sufficient explanation and informed written consent of their own free will to participate in this study.

Key exclusion criteria

1) Past medical history: Those who have been diagnosed with hypertension, blood disease, hyperlipidemia, or heart disease, whether present or in the past.
2) Oral medications: Those using antihypertensive drugs, blood flow improving drugs, ischemic heart disease treatment drugs, antiplatelet drugs, and anticoagulants. (Patients who had previously stopped taking medication for this surgery are also considered to be on medication)
3) Conditions of the upper arm: Conditions in which it is difficult to avascularize the upper arm.
4) Surgery time: Surgery time exceeds 4 hours.
5) Surgery/anesthesia: Surgery that differed from the planned procedure and required blood transfusion due to massive bleeding.
6) Other patients deemed unsuitable as research subjects by the research director (co-investigator)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Kojima

Organization

Asahi General Hospital

Division name

Department of anesthesiology

Zip code

25892511

Address

I 1326, Asahi city, Chiba.

TEL

0479638111

Email

cojicoji1109@gmail.com


Public contact

Name of contact person

1st name Yukii
Middle name
Last name Kojima

Organization

Asahi General Hospital

Division name

Department of Anesthesiology

Zip code

2892511

Address

I 1326, Asahi city, Chiba.

TEL

0479638111

Homepage URL


Email

cojicoji1109@gmail.com


Sponsor or person

Institute

Asahi General Hospital

Institute

Department

Personal name



Funding Source

Organization

Asahi General Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahi Chuo Medical Hospital Ethics Review Committee

Address

I 1326, Asahi city, Chiba.

Tel

0479638111

Email

agh060435@hospital.asahi.chiba.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2023011154

Org. issuing International ID_1

Asahi General Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 10 Month 05 Day

Date of IRB

2023 Year 09 Month 15 Day

Anticipated trial start date

2023 Year 10 Month 17 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 17 Day

Last modified on

2024 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059928


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name